Context Therapeutics Inc (CNTX)
1.85
-0.01
(-0.54%)
USD |
NASDAQ |
Sep 27, 16:00
1.85
0.00 (0.00%)
After-Hours: 18:15
Context Therapeutics Price: 1.85 for Sept. 27, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Sep 26, 2024 | 1.94 | 2.00 | 1.845 | 1.86 | 138386.0 |
Sep 25, 2024 | 1.97 | 2.055 | 1.895 | 1.93 | 66286.00 |
Sep 24, 2024 | 2.11 | 2.192 | 1.93 | 1.96 | 160415.0 |
Sep 23, 2024 | 2.25 | 2.359 | 2.06 | 2.08 | 261017.0 |
Sep 20, 2024 | 2.39 | 2.50 | 2.23 | 2.26 | 1.426M |
Sep 19, 2024 | 1.96 | 2.23 | 1.96 | 2.23 | 48534.00 |
Sep 18, 2024 | 2.10 | 2.115 | 1.94 | 1.96 | 100541.0 |
Sep 17, 2024 | 2.05 | 2.10 | 2.04 | 2.08 | 29331.00 |
Sep 16, 2024 | 2.04 | 2.14 | 2.03 | 2.08 | 62073.00 |
Sep 13, 2024 | 2.211 | 2.23 | 2.031 | 2.09 | 69445.00 |
Sep 12, 2024 | 2.11 | 2.25 | 2.11 | 2.15 | 133702.0 |
Sep 11, 2024 | 2.14 | 2.18 | 2.05 | 2.14 | 49589.00 |
Sep 10, 2024 | 2.12 | 2.19 | 2.09 | 2.13 | 85488.00 |
Sep 09, 2024 | 2.31 | 2.31 | 2.10 | 2.14 | 133897.0 |
Sep 06, 2024 | 2.30 | 2.38 | 2.208 | 2.32 | 96310.00 |
Sep 05, 2024 | 2.40 | 2.44 | 2.28 | 2.28 | 88472.00 |
Sep 04, 2024 | 2.45 | 2.55 | 2.34 | 2.43 | 71805.00 |
Sep 03, 2024 | 2.47 | 2.50 | 2.420 | 2.45 | 19469.00 |
Aug 30, 2024 | 2.47 | 2.49 | 2.43 | 2.46 | 27021.00 |
Aug 29, 2024 | 2.47 | 2.52 | 2.41 | 2.45 | 68871.00 |
Aug 28, 2024 | 2.45 | 2.53 | 2.45 | 2.46 | 90501.00 |
Aug 27, 2024 | 2.58 | 2.62 | 2.45 | 2.50 | 70230.00 |
Aug 26, 2024 | 2.47 | 2.53 | 2.41 | 2.50 | 107421.0 |
Aug 23, 2024 | 2.51 | 2.545 | 2.41 | 2.48 | 116936.0 |
Aug 22, 2024 | 2.47 | 2.56 | 2.47 | 2.50 | 33809.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.482
Minimum
May 04 2023
7.45
Maximum
Oct 25 2021
1.677
Average
1.36
Median
May 09 2022
Price Benchmarks
Collegium Pharmaceutical Inc | 38.27 |
NovaBay Pharmaceuticals Inc | 0.7008 |
Palatin Technologies Inc | 0.84 |
iBio Inc | 2.075 |
Theriva Biologics Inc | 1.47 |
Price Related Metrics
Price to Book Value | 1.372 |
Earnings Yield | -57.30% |
Market Cap | 138.75M |